A detailed history of Susquehanna International Group, LLP transactions in Alector, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 20,692 shares of ALEC stock, worth $101,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,692
Previous 48,826 57.62%
Holding current value
$101,804
Previous $293,000 68.26%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$4.19 - $6.23 $117,881 - $175,274
-28,134 Reduced 57.62%
20,692 $93,000
Q1 2024

May 07, 2024

SELL
$5.69 - $8.08 $172,856 - $245,462
-30,379 Reduced 38.35%
48,826 $293,000
Q4 2023

Feb 14, 2024

SELL
$3.77 - $8.39 $14,948 - $33,266
-3,965 Reduced 4.77%
79,205 $632,000
Q3 2023

Nov 14, 2023

BUY
$5.2 - $8.77 $176,207 - $297,180
33,886 Added 68.76%
83,170 $538,000
Q2 2023

Aug 11, 2023

SELL
$5.86 - $7.93 $607,869 - $822,594
-103,732 Reduced 67.79%
49,284 $296,000
Q1 2023

May 16, 2023

BUY
$5.85 - $9.84 $541,979 - $911,636
92,646 Added 153.46%
153,016 $947,000
Q4 2022

Feb 14, 2023

SELL
$6.88 - $9.55 $926,570 - $1.29 Million
-134,676 Reduced 69.05%
60,370 $557,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $1.46 Million - $2.35 Million
177,667 Added 1022.31%
195,046 $1.85 Million
Q2 2022

Aug 15, 2022

SELL
$7.65 - $14.24 $384,328 - $715,403
-50,239 Reduced 74.3%
17,379 $177,000
Q1 2022

May 16, 2022

SELL
$13.02 - $20.78 $1.47 Million - $2.35 Million
-112,864 Reduced 62.53%
67,618 $964,000
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $1.23 Million - $1.62 Million
63,415 Added 54.17%
180,482 $3.73 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $89,869 - $163,922
4,151 Added 3.68%
117,067 $2.67 Million
Q2 2021

Aug 11, 2021

BUY
$15.5 - $22.48 $511,531 - $741,884
33,002 Added 41.3%
112,916 $2.35 Million
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $190,753 - $285,744
12,854 Added 19.17%
79,914 $1.61 Million
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $720,472 - $1.28 Million
-76,646 Reduced 53.34%
67,060 $1.02 Million
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $1.37 Million - $3.24 Million
129,648 Added 922.24%
143,706 $1.51 Million
Q2 2020

Aug 14, 2020

SELL
$21.87 - $33.11 $981,897 - $1.49 Million
-44,897 Reduced 76.15%
14,058 $344,000
Q1 2020

May 15, 2020

BUY
$16.25 - $35.28 $958,018 - $2.08 Million
58,955 New
58,955 $1.42 Million
Q4 2019

Feb 14, 2020

SELL
$14.17 - $20.3 $289,733 - $415,074
-20,447 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$14.42 - $22.2 $294,845 - $453,923
20,447 New
20,447 $295,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $406M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.